101 related articles for article (PubMed ID: 3440336)
1. Anti-cardiolipin antibodies in progressive systemic sclerosis (PSS).
Bamberga P; Asero R; Vismara A; Brucato A; Riboldi P; Meroni PL
Clin Exp Rheumatol; 1987; 5(4):387-8. PubMed ID: 3440336
[No Abstract] [Full Text] [Related]
2. Anticardiolipin antibodies in systemic sclerosis: immunological and clinical associations.
Malia RG; Greaves M; Rowlands LM; Lawrence AC; Hume A; Rowell NR; Moult J; Holt CM; Lindsey N; Hughes P
Clin Exp Immunol; 1988 Sep; 73(3):456-60. PubMed ID: 2974767
[TBL] [Abstract][Full Text] [Related]
3. [Comment on the dissertation: Kapiotis, ST: Anti-cardiolipin antibodies in venous thromboses].
Eber B
Wien Klin Wochenschr; 1991; 103(7):212. PubMed ID: 2063588
[No Abstract] [Full Text] [Related]
4. [Anti-cardiolipin antibodies in beta-thalassemia].
Nasonova VA; Musaev SK; Kovalev VIu; Asadov CH; Nasonov EL
Klin Med (Mosk); 1991 Aug; 69(8):37-40. PubMed ID: 1791705
[No Abstract] [Full Text] [Related]
5. Anti-IgE autoantibodies in systemic sclerosis (scleroderma).
Kaufman LD; Gruber BL; Marchese MJ; Seibold JR
Ann Rheum Dis; 1989 Mar; 48(3):201-5. PubMed ID: 2930275
[TBL] [Abstract][Full Text] [Related]
6. Anticardiolipin antibodies in systemic sclerosis.
Fonollosa V; Selva A; Lima J; Simeon CP; Vilardell M
J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):133-4. PubMed ID: 1880247
[No Abstract] [Full Text] [Related]
7. Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis.
Katayama I; Otoyama K; Kondo S; Nishioka K; Nishiyama S
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 1):198-201. PubMed ID: 2212115
[TBL] [Abstract][Full Text] [Related]
8. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
[TBL] [Abstract][Full Text] [Related]
9. [Why are there anti-cardiolipin antibodies in patients with infectious mononucleosis and in patients with systemic lupus erythematosus?].
Dostál C; Palecková A; Novák M; Jahn M; Dostál C
Vnitr Lek; 1990 Nov; 36(11):1050-6. PubMed ID: 2267733
[TBL] [Abstract][Full Text] [Related]
10. Progressive systemic sclerosis: autoimmune arteriopathy.
Evans DJ; Cashman SJ; Walport M
Lancet; 1987 Feb; 1(8531):480-2. PubMed ID: 2881042
[TBL] [Abstract][Full Text] [Related]
11. [Latent autoantibodies to cardiolipin in the blood serum of healthy subjects].
Saenko VA; Rott GM; Poverennyĭ AM
Biull Eksp Biol Med; 1989 Feb; 107(2):217-9. PubMed ID: 2923980
[TBL] [Abstract][Full Text] [Related]
12. Elevated IGG and IGM anticardiolipin antibodies in a subgroup of medicated and unmedicated schizophrenic patients.
Chengappa KN; Carpenter AB; Keshavan MS; Yang ZW; Kelly RH; Rabin BS; Ganguli R
Biol Psychiatry; 1991 Oct; 30(7):731-5. PubMed ID: 1683585
[No Abstract] [Full Text] [Related]
13. [Antiphospholipid antibodies, thrombosis and lupus disease. Value of the assay of anticardiolipin antibodies by the ELISA technic].
Meyer O; Cyna L; Borda-Iriarte O; Jungers P; Piette JC; Dautzenberg MD; Dupuy E; Ryckewaert A
Rev Rhum Mal Osteoartic; 1985 May; 52(5):297-305. PubMed ID: 3874416
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid antibodies: clinical significance in systemic lupus erythematosus].
Zhou DC; Dong Y; Pan JQ
Zhonghua Nei Ke Za Zhi; 1989 Feb; 28(2):78-80, 125. PubMed ID: 2500316
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to cardiolipin in stroke: association with mortality and functional recovery in patients without systemic lupus erythematosus.
Chakravarty KK; Byron MA; Webley M; Durkin CJ; al-Hillawi AH; Bodley R; Wozniak J
Q J Med; 1991 May; 79(289):397-405. PubMed ID: 1924675
[TBL] [Abstract][Full Text] [Related]
16. Non-specific autoantibodies in cardiomyopathies and myocardial infarction.
Syrigou EI; Konstandoulakis MM; Syrigos KN; Kroubouzou H; Kokotou E; Toutouzas P
J Clin Lab Immunol; 1995; 46(4):155-62. PubMed ID: 8733028
[TBL] [Abstract][Full Text] [Related]
17. Detection of anti-phospholipid (cardiolipin, phosphatidylserine) antibodies in the serum of patients with non insulin-dependent (type 2) diabetes mellitus and macroangiopathy. Coexistence of anti-platelet reactivity.
Triolo G; Giardina E; Scarantino G; Seddio G; Bompiani G
Diabetes Res; 1989 Feb; 10(2):63-7. PubMed ID: 2743710
[TBL] [Abstract][Full Text] [Related]
18. [Modification of B-cell precursor frequencies by systemic photochemotherapy (PUVA) in patients with systemic scleroderma].
Kunzelmann V; Brenke A; Fetscher I; Lukowsky A; Leschik G; Adrian K; Sönnichsen N
Z Arztl Fortbild (Jena); 1994 Aug; 88(7-8):519-24. PubMed ID: 7856255
[No Abstract] [Full Text] [Related]
19. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA
Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
[No Abstract] [Full Text] [Related]
20. Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity.
Colaço CB; Scadding GK; Lockhart S
Clin Exp Immunol; 1987 May; 68(2):313-9. PubMed ID: 3498571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
